Biolexis Therapeutics Inc.
Industry: Biotechnology (See others in industry)
Address:
3900 N Traverse Mountain Blvd Suite 200
Lehi, UT, 84043
Phone: 801-328-3600
Lehi, UT, 84043
Phone: 801-328-3600
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-03 | New | $1,600,000 | $1,600,000 | Other | 06b | SEC link |
| 2023-10-17 | New | $1,000,000 | $1,000,000 | Equity Only | 06b | SEC link |
| 2023-10-03 | New | $725,000 | $725,000 | Equity Only | 06b | SEC link |
| 2022-09-02 | New | $1,500,000 | $1,500,000 | Equity Only | 06b | SEC link |
| 2022-03-01 | New | $1,500,000 | $1,500,000 | Debt Only | 06b | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Dr. David J. Bearss | Director, Executive |
| David J. Bearss | Director |
| James N. Clarke | Director |
| Tyler Hartmann | Executive |
| Anthony Steve | Director |
| David O. Taylor | Director, Executive |
| Dr. Hariprasad Vankayalapati | Director, Executive |
| Hariprasad Vankayalapati | Director |